MedTrace Logo

Protocol: Phytomedicine-AMARGOL®, Clinical Trial for Efficacy Proof on Therapeutics

NCT01485328 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-12-06

No results posted yet for this study

Summary

This is a Phase 3: Efficacy Study for AMARGOL® a phytomedicine used for asymptomatic digestive complaints.

Conditions

  • Digestive System Disorders

Interventions

DRUG

AMARGOL®

per oral solution, 40 mL single dose

Sponsors & Collaborators

  • Phytopharm Consulting Brazil

    collaborator NETWORK

  • Laboratorio Saude Ltda.

    lead INDUSTRY

Principal Investigators

  • Angelo G Chaves, Doctor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-04-30
Completion
2009-09-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01485328 on ClinicalTrials.gov